Medera’s SPAC Merger Marks Rare Biotech Move
Medera aims for Nasdaq listing via SPAC to boost gene therapies, spotlighting rare biotech SPACs in 2024.
- Latest
- Trending
Medera aims for Nasdaq listing via SPAC to boost gene therapies, spotlighting rare biotech SPACs in 2024.
Stifel downgrades Medtronic to 'Hold' due to slow growth in key initiatives like HUGO system, affecting market competitiveness.
Miami-based HealthSnap raises $25M in Series B funding for its remote patient monitoring and chronic care management solution. The company ...
Ultromics and Pfizer partner to advance AI detection of cardiac amyloidosis, aiming to revolutionize the management of the condition. FDA ...
Investors hail Minnesota's "Fantastic Four" local stocks, Hawkins Inc., APi Group, Winmark Corp., and CVRx, for outperforming in 2023.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.